Lack of discrimination against non-proteinogenic amino acid norvaline by elongation factor Tu from

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

1. Negative catalysis by the editing domain of class I aminoacyl-tRNA synthetases.Nucleic acids research · 2022
   Article
2. A discriminator code-based DTD surveillance ensures faithful glycine delivery for protein biosynthesis in bacteria.eLife · 2018
   Article
3. Role of D-aminoacyl-tRNA deacylase beyond chiral proofreading as a cellular defense against glycine mischarging by AlaRS.eLife · 2017
   Article
4. Proteome-wide measurement of non-canonical bacterial mistranslation by quantitative mass spectrometry of protein modifications.Scientific reports · 2016
   Article
5. Elongation Factor Tu Prevents Misediting of Gly-tRNA(Gly) Caused by the Design Behind the Chiral Proofreading Site of D-Aminoacyl-tRNA Deacylase.PLoS biology · 2016
   Article
6. Naturally Occurring Isoleucyl-tRNA Synthetase without tRNA-dependent Pre-transfer Editing.The Journal of biological chemistry · 2016
   Article
7. Norvaline and norleucine may have been more abundant protein components during early stages of cell evolution.Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life · 2013
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as